As of 2025-10-16, the Relative Valuation of Cytosorbents Corp (CTSO) is (6.24) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.92 USD, the upside of Cytosorbents Corp based on Relative Valuation is -780.9%.
The range of the Relative Valuation is (6.10) - (6.20) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 39.2x - 46.4x | 44.1x |
| Forward P/E multiples | 32.9x - 39.9x | 36.2x |
| Fair Price | (6.10) - (6.20) | (6.24) |
| Upside | -765.5% - -776.3% | -780.9% |
| Date | P/E |
| 2025-10-10 | -5.90 |
| 2025-10-09 | -6.00 |
| 2025-10-08 | -6.28 |
| 2025-10-07 | -6.09 |
| 2025-10-06 | -6.05 |
| 2025-10-03 | -6.33 |
| 2025-10-02 | -6.34 |
| 2025-10-01 | -6.01 |
| 2025-09-30 | -6.01 |
| 2025-09-29 | -5.96 |
| 2025-09-26 | -6.01 |
| 2025-09-25 | -5.96 |
| 2025-09-24 | -6.13 |
| 2025-09-23 | -6.19 |
| 2025-09-22 | -6.22 |
| 2025-09-19 | -6.06 |
| 2025-09-18 | -6.01 |
| 2025-09-17 | -5.82 |
| 2025-09-16 | -5.85 |
| 2025-09-15 | -5.89 |
| 2025-09-12 | -6.04 |
| 2025-09-11 | -6.14 |
| 2025-09-10 | -6.09 |
| 2025-09-09 | -6.42 |
| 2025-09-08 | -6.32 |
| 2025-09-05 | -6.22 |
| 2025-09-04 | -6.28 |
| 2025-09-03 | -6.31 |
| 2025-09-02 | -6.12 |
| 2025-08-29 | -6.07 |
| 2025-08-28 | -6.02 |
| 2025-08-27 | -5.99 |
| 2025-08-26 | -5.99 |
| 2025-08-25 | -5.83 |
| 2025-08-22 | -5.88 |
| 2025-08-21 | -5.43 |
| 2025-08-20 | -5.75 |
| 2025-08-19 | -6.95 |
| 2025-08-18 | -7.08 |
| 2025-08-15 | -7.47 |
| 2025-08-14 | -7.34 |
| 2025-08-13 | -6.95 |
| 2025-08-12 | -6.82 |
| 2025-08-11 | -7.72 |
| 2025-08-08 | -6.44 |
| 2025-08-07 | -5.75 |
| 2025-08-06 | -5.81 |
| 2025-08-05 | -5.89 |
| 2025-08-04 | -5.87 |
| 2025-08-01 | -5.60 |